LINC01116

ncRNA information

ncRNA name

LINC01116

Specific or universal ncRNAs

Universal ncRNAs

Class

Long noncoding RNA

Biomarker

Yes

Biomarker application

Treatment

Upstream regulatory factors

Not available

Downstream target

IFI44

Cancer information

Cancer name

Non-Small Cell Lung Cancer

Cancer site

Lung

Treatment information

Treatment type

Chemotherapy

Drug

Gefitinib

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Down

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

LINC01116 plays a critical role in geļ¬tinib resistance of NSCLC cells by affecting IFI44 expression, providing a novel therapeutic target to overcome TKI resistance in NSCLC.

Tissue resource

human non-small cell lung cancer cell lines PC9

human non-small cell lung cancer cell lines PC9

Experiment

qRT-PCR,Western blot


Institute

the cell bank of the Chinese Academy of Sciences

Chinese Academy of Sciences

Country

China

China

Continent

Asia

Asia